Royal Bank of Canada’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-34
Closed -$1K 7245
2024
Q2
$1K Buy
34
+33
+3,300% +$642 ﹤0.01% 6866
2024
Q1
$0 Sell
1
-21
-95% -$362 ﹤0.01% 7414
2023
Q4
$0 Buy
+22
New +$319 ﹤0.01% 7439
2023
Q3
Sell
-4
Closed 7418
2023
Q2
$0 Buy
4
+3
+300% +$59 ﹤0.01% 7530
2023
Q1
$0 Buy
+1
New +$19 ﹤0.01% 7347
2022
Q4
Sell
-14
Closed 7566
2022
Q3
$0 Sell
14
-3
-18% -$153 ﹤0.01% 7716
2022
Q2
$1K Hold
17
﹤0.01% 7167
2022
Q1
$1K Hold
17
﹤0.01% 7611
2021
Q4
$1K Hold
17
﹤0.01% 7516
2021
Q3
$1K Sell
17
-37
-69% -$3.24K ﹤0.01% 7488
2021
Q2
$6K Sell
54
-69
-56% -$7.06K ﹤0.01% 7030
2021
Q1
$15K Buy
123
+92
+297% +$13.3K ﹤0.01% 6602
2020
Q4
$4K Buy
31
+12
+63% +$1.55K ﹤0.01% 6737
2020
Q3
$2K Sell
19
-1
-5% -$123 ﹤0.01% 6331
2020
Q2
$5K Sell
20
-2
-9% -$761 ﹤0.01% 6040
2020
Q1
$10K Buy
22
+5
+29% +$2.67K ﹤0.01% 5830
2019
Q4
$11K Sell
17
-2
-11% -$1K ﹤0.01% 6107
2019
Q3
$7K Buy
19
+2
+12% +$650 ﹤0.01% 5897
2019
Q2
$3K Buy
+17
New +$3.53K ﹤0.01% 6485

Other funds holding NXTC

Royal Bank of Canada's NXTC Position: Q3 2024 in Review

Royal Bank of Canada sold out of NextCure (NXTC) in Q3 2024, closing a stake of 34 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in NXTC in Q2 2019 and held it in 19 quarters. The position peaked at $15K in Q1 2021. 43 funds tracked by Wall St. Rank hold NXTC as of Q3 2024.

  • Royal Bank of Canada reported no remaining NextCure position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 34 NextCure shares in Q3 2024, an estimated $1K.
  • Royal Bank of Canada first reported a position in NextCure in Q2 2019 and held it in 19 quarters.
  • Royal Bank of Canada's NextCure position peaked at $15K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held NextCure as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.